AT148005

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

ALX Oncology

Start Date

September 1, 2021

End Date

November 18, 2024

Awarded By

ALX Oncology

Start Date

September 1, 2021

End Date

November 18, 2024